EUVIMEDEUVIMED entdecken
Open Access

Dynamic Acquisition of [ 99m Tc]Tc-Pyrophosphate SPECT/CT Images in Transthyretin Cardiac Amyloidosis: A Pilot Study

Benjamin Auer, Alyssa De Moraes, Ardel J Romero Pabon, Olivier F Clerc, Sudhir Bhimaniya, Marie Foley Kijewski, Annu Kurian, Shilpa Vijayakumar, Sarah A M Cuddy, Marcelo F Di Carli, Sharmila Dorbala

Journal of Nuclear Medicine · 2025

DOI: 10.2967/jnumed.125.270405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Benjamin Auer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Technetium Tc 99m Pyrophosphate, Amyloid Neuropathies, Familial, Single Photon Emission Computed Tomography Computed Tomography, Cardiomyopathies. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, American Heart Association-American Stroke Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objectives of this study were to determine the timing of peak [99mTc]Tc-pyrophosphate uptake in the myocardium, blood pool, and bone and to explore the feasibility and advantage of early imaging compared with the standard late imaging in participants with and without transthyretin amyloid cardiomyopathy (ATTR-CM).

Methods

Dynamic [99mTc]Tc-pyrophosphate SPECT/CT data were acquired at 0-5 min and 10-65 min, with additional 15-min static scans at 90 and 150 min using a full-ring cadmium zinc telluride scanner. Image analysis included visual assessment and established quantitative metrics that require calibrated SPECT images, such as SUVmean and SUVmax and percentage injected dose per milliliter, along with relative uptake ratios (myocardium to bone and myocardium to blood pool) that do not require calibration. ATTR-CM and non-ATTR-CM cohorts were compared.

Results

Our study included 19 participants: 8 with ATTR-CM (median age of 80 y with an interquartile range of 9.3 y) and 11 (57.9%) without ATTR-CM. In ATTR-CM, SUVmean was significantly higher in the myocardium than in the blood pool at 10 min (3.86 ± 0.77 vs. 3.08 ± 0.58, P = 0.0055). Myocardial SUVmean remained elevated over time, with a statistically significant decline from 3.86 ± 0.77 at 10 min to 2.88 ± 0.57 at 150 min (P = 0.0025). In patients without ATTR-CM, myocardial SUVmean remain relatively stable across all time points (1.24 ± 0.41 at 10 min to 0.94 ± 0.21 at 150 min, P = not statistically significant). In both groups, bone SUVmean peaked at 90 min, and the blood pool showed the highest SUV at 10 min, followed by a decrease through 150 min. Percentage injected dose per milliliter clearly separated the ATTR-CM from the non-ATTR-CM groups at all time points.

Conclusion

In participants with ATTR-CM, myocardial uptake peaked by 10 min after injection and remained stable, with minimal washout, through 150 min; non-ATTR-CM participants showed consistently lower myocardial uptake than blood pool uptake at all time points. These findings suggest that early imaging can perform as well as late imaging for diagnosis of ATTR-CM, supporting the potential of early imaging to streamline patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Technetium Tc 99m PyrophosphateAmyloid Neuropathies, FamilialSingle Photon Emission Computed Tomography Computed TomographyCardiomyopathiesHumansPilot ProjectsMaleFemaleAgedAged, 80 and overMiddle AgedImage Processing, Computer-Assisted

Stichwörter der Autor:innen

[99mTc]Tc-pyrophosphatedynamic SPECT imagingquantitative SPECTtransthyretin cardiac amyloidosis

Substanzen

Technetium Tc 99m Pyrophosphate

Autor:innen und Institutionen

  • Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts sdorbala@bwh.harvard.edu.

Förderung

  • NHLBI NIH HHS
  • American Heart Association-American Stroke Association

Zitieren

APA

Auer, B., De Moraes, A., Pabon, A. J. R., Clerc, O. F., Bhimaniya, S., Kijewski, M. F., Kurian, A., Vijayakumar, S., Cuddy, S. A. M., Di Carli, M. F., & Dorbala, S. (2025). Dynamic Acquisition of [ 99m Tc]Tc-Pyrophosphate SPECT/CT Images in Transthyretin Cardiac Amyloidosis: A Pilot Study. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.270405

Vancouver

Auer B, De Moraes A, Pabon AJR, Clerc OF, Bhimaniya S, Kijewski MF, et al. Dynamic Acquisition of [ 99m Tc]Tc-Pyrophosphate SPECT/CT Images in Transthyretin Cardiac Amyloidosis: A Pilot Study. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.125.270405

BibTeX
@article{Auer2025,
  author = {Auer, Benjamin and De Moraes, Alyssa and Pabon, Ardel J Romero and Clerc, Olivier F and Bhimaniya, Sudhir and Kijewski, Marie Foley and Kurian, Annu and Vijayakumar, Shilpa and Cuddy, Sarah A M and Di Carli, Marcelo F and Dorbala, Sharmila},
  title = {Dynamic Acquisition of [ 99m Tc]Tc-Pyrophosphate SPECT/CT Images in Transthyretin Cardiac Amyloidosis: A Pilot Study},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  doi = {10.2967/jnumed.125.270405}
}
Kostenlos starten →